Alnylam Pharmaceuticals
ALNY
#653
Rank
S$49.85 B
Marketcap
S$373.40
Share price
0.20%
Change (1 day)
-10.71%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company